SAINT for MDD in an Inpatient Setting Follow-on
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brandon Bentzley, MD
Magnus Medical
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Iowa
Iowa City, Iowa, United States
- Weill Cornell Medicine
Manhattan, New York, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas, Ausin - Department of Psychiatry and Behavioral Sciences
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2024
- Primary completion
- 6 Mar 2025
- Completion
- 6 Mar 2025
- Last update posted
- 24 Mar 2025
- Registered enrollment
- 2
- Registry id
- NCT06462820
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.